Literature DB >> 14578303

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.

Dana Dabelea1, Gregory Kinney, Janet K Snell-Bergeon, John E Hokanson, Robert H Eckel, James Ehrlich, Satish Garg, Richard F Hamman, Marian Rewers.   

Abstract

The objective of this is study was to examine whether estimated insulin resistance and insulin resistance-related factors are associated with coronary artery calcification (CAC) in 1,420 asymptomatic participants in the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. A total of 656 patients with type 1 diabetes and 764 control subjects aged 20-55 years were examined. CAC was assessed by electron-beam computed tomography. Insulin resistance was computed with linear regression based on an equation previously validated in clamp studies on type 1 diabetic adults. Insulin resistance was associated with CAC (OR 1.6 in type 1 diabetes and 1.4 in control subjects, P < 0.001), independent of coronary artery disease risk factors. There was a male excess of CAC in control subjects (OR 2.7, adjusted for age, smoking, and LDL and HDL cholesterol levels) and in type 1 diabetic patients (OR 2.2, adjusted for the same factors and diabetes duration). After adjusting for insulin resistance, the CAC male excess in diabetic patients decreased from OR 2.2 (P < 0.001) to 1.8 (P = 0.04). After adjustment for waist-to-hip ratio, waist circumference, or visceral fat, the gender difference in CAC was not significant in diabetic subjects. In conclusion, gender differences in insulin resistance-associated fat distribution may explain why type 1 diabetes increases coronary calcification in women relatively more than in men.

Entities:  

Mesh:

Year:  2003        PMID: 14578303     DOI: 10.2337/diabetes.52.11.2833

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  109 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

2.  Adiponectin dysregulation and insulin resistance in type 1 diabetes.

Authors:  Rocio I Pereira; Janet K Snell-Bergeon; Christopher Erickson; Irene E Schauer; Bryan C Bergman; Marian Rewers; David M Maahs
Journal:  J Clin Endocrinol Metab       Date:  2012-01-25       Impact factor: 5.958

3.  Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.

Authors:  Melanie Cree-Green; Bryan C Bergman; Eda Cengiz; Larry A Fox; Tamara S Hannon; Kellee Miller; Brandon Nathan; Laura Pyle; Darcy Kahn; Michael Tansey; Eileen Tichy; Eva Tsalikian; Ingrid Libman; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 4.  Diabetic dyslipidemia and cardiovascular risk.

Authors:  Robert H Eckel
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

5.  Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.

Authors:  Petter Bjornstad; Pattara Wiromrat; Richard J Johnson; Rachel Sippl; David Z I Cherney; Randy Wong; Marian J Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2018-11-27       Impact factor: 19.112

6.  An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype.

Authors:  Nina S Levy; Moshe Vardi; Shany Blum; Rachel Miller-Lotan; Yefim Afinbinder; Patricia A Cleary; Andrew D Paterson; Bhupinder Bharaj; Janet K Snell-Bergeon; Marian J Rewers; Orit Lache; Andrew P Levy
Journal:  Clin Chem Lab Med       Date:  2013-08       Impact factor: 3.694

7.  Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule.

Authors:  Y Vergouwe; S S Soedamah-Muthu; J Zgibor; N Chaturvedi; C Forsblom; J K Snell-Bergeon; D M Maahs; P-H Groop; M Rewers; T J Orchard; J H Fuller; K G M Moons
Journal:  Diabetologia       Date:  2009-11-04       Impact factor: 10.122

8.  Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.

Authors:  David M Maahs; Janet K Snell-Bergeon; John E Hokanson; Gregory L Kinney; Tomas Berl; Marian Rewers; Lorraine G Ogden
Journal:  Diabetes Technol Ther       Date:  2010-01       Impact factor: 6.118

9.  Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.

Authors:  Ying Zhang; Alicia J Jenkins; Arpita Basu; Julie A Stoner; Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons
Journal:  J Lipid Res       Date:  2015-12-09       Impact factor: 5.922

Review 10.  Vascular calcification in diabetes: mechanisms and implications.

Authors:  Janet K Snell-Bergeon; Matthew J Budoff; John E Hokanson
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.